Go Back

MEDIFY NEXUS PRIVATE LIMITED

Medify

U72900MH2021PTC357335

Get Comprehensive Report

₹1,999.00 ₹3,998.00
Suggest Edit Last updated: Mar 10, 2025
Key Metrics
  • No. of Employees5
  • Founded Year 2021
  • Company StagePrivate Limited Company
  • Total Funding₹8.28 Cr
  • Industry

  • Headquarter
  • Company StatusActive
About Medify

Medify provides Medical Practitioners and Retail Pharmacies with a platform that enables improved Information Management, Data Analytics, Hierarchical Access Monitoring and Patient Retention, for Primary Healthcare Providers.

Business Model

Medify is a healthcare platform that connects doctors, pharmacies, and patients. It allows doctors to manage their patients, pharmacies to manage their inventory, and patients to book appointments, refill prescriptions, and access medical records.

Top Competitors
MF
MfineU85100KA2017PTC100587
PR
PractoU72900KA2008PTC046374
ME
MedibuddyU72300TN2013PTC092385
Medify Funding Details
Funding Highlights
Latest Funding RoundSeed
Total Funding Raised₹8.28 Cr
No. of Investments Made0
Total No. of Acquisitions0
Lead Investors2
Investors
  • Authum Investment & Infrastructure,Global Media Ventures
Funding Details
TheKredible's detailed funding report contains info about Funding raised by the company along with Lead Investors, Investors, Shareholding Strcuture, and its Investments & Acquisitions.
₹799.00 ₹1,598.00
Funding History
TheKredible's 'Funding History' report provides deep insights of Funding with list of Lead Investors
₹399.00 ₹798.00
Funding Per Year
A Funding report of the company's overall funding on yearly basis, segregated by the team TheKredible.
₹199.00 ₹398.00
Medify Financial Details
Financial Highlights
FY 2023-24 Revenue₹69.62 Lakh
FY 2023-24 Expenses₹2.55 Cr
FY 2023-24 Profit/Loss-₹1.85 Cr
Net Cash Flow From Operations-₹1.64 Cr
Full Financial Details
Detailed report containing info about Business Model, year-wise Financial Comparison, Ratio Analysis and detailed Revenue and Expense breakdowns.
₹799.00 ₹1,598.00
Financial Comparison
A detailed report of year-wise Financial Comparison of the company
₹430.00 ₹860.00
Revenue Breakdown
A report and breakdown of the company's year-wise revenue streams.
₹399.00 ₹798.00
Expense Breakdown
A report and breakdown of the company's year-wise expenditures.
₹399.00 ₹798.00
Shareholding Structure
Team at TheKredible has gone through several ROC filings and portrayed Shareholding Structure of the company.
₹499.00 ₹998.00
Financial Ratio
Analysis of Financial Ratios which gives quick insights about the company's profitability and capital efficiency.
₹199.00 ₹398.00
Medify Key People
People Metrics
Current Core Team1
Board Members/Directors2

Core Team

KS
Kairav ShahCo-Founder & CEO

Board Members/Directors

KB
Kairav Bakulesh ShahDirector
BT
Bakulesh Trambaklal ShahDirector
Medify Documents

AY - 2021-22

Profit and Loss statement - Medify - 2021-22.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Medify for FY 2021-22.
₹249.00 ₹498.00
Balance Sheet - Medify - 2021-22.pdf
TheKredible's experts has summarized the Balance Sheet of Medify for FY 2021-22.
₹249.00 ₹498.00

AY - 2022-23

Profit and loss statement - Medify - 2022-23.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Medify for FY 2022-23
₹249.00 ₹498.00
Balance sheet - Medify - 2022-23.pdf
TheKredible's experts has summarized the Balance Sheet of Medify for FY 2022-23
₹249.00 ₹498.00

AY - 2023-24

Profit and loss statement - Medify - 2023-24.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Medify for FY 2023-24
₹249.00 ₹498.00
Balance sheet - Medify - 2023-24.pdf
TheKredible's experts has summarized the Balance Sheet of Medify for FY 2023-24
₹249.00 ₹498.00

Subscribe to our newsletter to stay updated

Weekly Funding Reports
Funding Report
Weekly Funding Report [09 Jun- 13 Jun, 2025]
Monthly Funding Reports
Funding Report
Indian startups raised a total of $1.14 billion ac...

Get your Customised Report

With an exclusive 20% off on your order

Latest Industry Reports
Industry Report
HealthTech’s Rebound: After a Downturn, HealthTech...